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SUMMARY. The methanol extract of the whole plant of Eclipta prostrata and one of its isolated com-
pounds, eclalbasaponin II were administered to alloxan-induced diabetic rats for 28 and 7 consecutive
days, respectively. During the study, a potent antidiabetic activity was observed. Blood sugar was signifi-
cantly (p < 0.001) reduced by E. prostrata extract (300 mg/kg) and eclalbasaponin II (10 mg/kg), as com-
pared to untreated diabetic rats. Analyses of alanine aminotransferase (ALT), aspartate aminotransferase
(AST) and alkaline phosphatase (ALP) showed no significant (p < 0.001) hepatotoxicity by E. prostrata ex-
tractive in alloxan-induced diabetic rats when compared to the diabetic control rats.
